About: Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2001 (uk) im März 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2001 (ast) scientific article published on 01 March 2001 (en)
publication date	wds:Q59548339-2C468CC7-ED29-4DA4-8751-487903B6EB2A
publication date	2001-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59548339-ED07A714-B2A0-4710-BAA0-226B9CBC30A8
language of work or name	English
author name string	wds:Q59548339-16A2B69B-53DB-47D3-855A-D9506E0C35B9 wds:Q59548339-26F8ED0E-63F0-4DA7-8FC5-78084A7CA7FC wds:Q59548339-408632FB-4322-49E8-9A69-313D9388AFBD wds:Q59548339-4C387BE3-D760-4193-B8F6-B73D95BB8416 wds:Q59548339-5FA4043E-2423-4891-ACE8-9708F773D0F0 wds:Q59548339-68598321-E63A-490A-BBE7-A755F062CDEF wds:Q59548339-8C9C201C-4358-4D93-821A-14EEA72ECFC9 wds:Q59548339-95B6DB52-8436-4DD6-922E-DD368290D5C1 wds:Q59548339-9F120DE3-AB3B-4D4E-9190-E2CAB5128ACB wds:Q59548339-B677286C-12FF-459B-A74F-9A574DB1EBA5 wds:Q59548339-D9F53E56-F1D3-4768-A256-C3C3B6240170 wds:Q59548339-E885BD6C-4D9E-4DBD-BFE3-FAE34C212639 wds:Q59548339-FE0EB09C-A767-444A-B2D0-F98870F46E76
author name string	A Fischer J Wijdenes J M Seigneurin P Hubert D Debray S Paczesny V Leblond C Duvoux E Haddad V Delwail B Hurault de Ligny A Achkar M Bauwens
rdfs:label	Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (en) Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (nl)
skos:prefLabel	Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (en) Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (nl)
name	Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (en) Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (nl)
author	wds:Q59548339-0D1634D5-2342-4F7A-A3FB-0012D08DD15E wds:Q59548339-6365779F-84B3-4008-B0D8-43D0745255E0
author	Anne Durandy Marc Stern
title	wds:Q59548339-1FB92805-0073-4C32-817A-F40C5F8040C9
title	Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial (en)
page(s)	wds:Q59548339-4DC0D18B-5FC4-4197-A769-C69335AC32B9
page(s)	1590-1597
instance of	wds:Q59548339-736CB858-B1E4-414C-B34F-E4AD8B220812
instance of	scholarly article
main subject	wds:Q59548339-0A0A586F-F4B5-4674-8B53-073F81FF3C45 wds:Q59548339-1D2F2886-E6DE-4057-ABC4-69D1359FF86C wds:Q59548339-395b6e92-e246-4bf4-ae50-459f7a1c9ab8
main subject	interleukins phase I clinical trial multicenter clinical trial
PubMed ID	wds:Q59548339-89D67531-B3EE-4F22-A6E1-8FE1CE807A56
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11238096
PubMed ID	11238096
published in	wds:Q59548339-B69FC4A5-9C7C-4B8C-984C-971BC3D3FA79
published in	Blood
issue	wds:Q59548339-67DEBCBF-4FA3-48B3-907D-E7D004BEA527
volume	wds:Q59548339-4C583636-481E-4EFB-9198-E040E24E39B2
issue	6
volume	97
DOI	wds:Q59548339-C64F0358-88B0-456A-ADDD-5C936F2F2475
DOI	http://dx.doi.org/10.1182/BLOOD.V97.6.1590
DOI	10.1182/BLOOD.V97.6.1590
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59548339
is cites work of	Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors Post-transplant lymphoproliferative disorders Post-transplant lymphoproliferative disorder: a review Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus Interleukin-6 and its receptor in cancer: implications for translational therapeutics Epstein-Barr virus in patients with immunodeficiency disorders IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells Therapeutic options in post-transplant lymphoproliferative disorders Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide Treatment of Epstein-Barr virus-associated malignancies with specific T cells Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management The management of posttransplant lymphoproliferative disorder Cytokine traps: multi-component, high-affinity blockers of cytokine action Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants Post-transplant lymphoproliferative disorders Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation Epstein-Barr virus associated disease following blood or marrow transplant Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software